D. Marks

M. Aljurf, M. Horowitz, R. Gale, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Providing personalized prognostic information for adult leukemia survivors.

Alan M. Miller, B. Storer, B. George, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD

G. Mufti, J. Scarisbrick, J. Cavenagh, 2012, Bone Marrow Transplantation.

Immune reconstitution following umbilical cord blood transplantation: IRES, a study of UK paediatric patients

P. Veys, R. Hough, A. Vora, 2020, EJHaem.

Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.

J. Fay, W. Wood, J. Maciejewski, 2018, Leukemia research.

The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study

N. Russell, G. Cook, D. Marks, 2010, Bone Marrow Transplantation.

Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improves Transplant Outcomes in Older MDS Patients.

M. Aljurf, J. Szer, R. Gale, 2021, Transplantation and cellular therapy.

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

Alan M. Miller, R. Vij, W. Wood, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States.

A. Zander, M. Horowitz, J. Liesveld, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation.

M. Sorror, M. Krem, M. Pasquini, 2021, Transplantation and cellular therapy.

Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy: Guidelines for Hematopoietic Transplantation and Cellular Therapy.

S. Crawford, P. Veys, R. Champlin, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Aspergillus antigen testing in bone marrow transplant recipients

Elizabeth M. Johnson, E. Johnson, D. Warnock, 2000, Journal of clinical pathology.

transplantation for follicular lymphoma Comparison of autologous and allogeneic hematopoietic stem cell

J. Armitage, J. Vose, M. Horowitz, 2013 .

Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.

M. Norkin, W. Wood, M. Sorror, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma.

S. Montoto, P. Hari, D. Maloney, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients

H. Kantarjian, G. Garcia-Manero, J. Cortes, 2020, Leukemia & lymphoma.

The effect of pretransplant interferon therapy on the outcome of unrelated donor hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in first chronic phase.

J. Klein, M. Horowitz, C. Anasetti, 2001, Blood.

How many serial sections are needed to detect apoptosis in endoscopic biopsies with gastrointestinal graft versus host disease?

N. Wong, D. Marks, 2019, Journal of Clinical Pathology.

Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research.

S. Montoto, P. Hari, D. Maloney, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTR.

J. Vose, J. Winter, P. Hari, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recent Developments in the Management of T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma

A. Fielding, D. Marks, L. Banerjee, 2012, Current Hematologic Malignancy Reports.

Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).

M. Sorror, J. Wingard, M. Gilleece, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial

A. Fielding, T. Menne, A. Fielding, 2016, Leukemia.

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia.

M. Tallman, L. Foroni, G. Gerrard, 2014, Blood.

The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System Analysis

W. Wood, D. Rizzieri, H. Lazarus, 2020 .

Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee.

M. Perales, J. Wingard, J. Pidala, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia Using Sibling and Volunteer Unrelated Donors: A Comparison of Complications in the First 2 Years

A. Barrett, J. Goldman, A. Schwarer, 1993, Annals of Internal Medicine.

New cancers after autotransplantations for multiple myeloma.

A. Krishnan, S. Lonial, P. Hari, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor lymphocyte infusions after reduced intensity conditioning allogeneic transplantation: what we need to know.

D. Marks, A. Parker, S. Robinson, 2004, Blood.

Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome.

G. Hale, H. Waldmann, J. Cornish, 1999, Blood.

Factors influencing the outcome of a second autologous stem cell transplant (ASCT) in relapsed multiple myeloma: a study from the British Society of Blood and Marrow Transplantation Registry.

G. Morgan, N. Russell, F. Davies, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Viral (polyomavirus) cystitis heralding cytomegalovirus infection

A. Barrett, J. Goldman, D. Marks, 1992, The Lancet.

Alemtuzumab-based therapy for Secondary Malignant Histiocytosis arising from Pre-B-ALL

D. Marks, J. Bird, M. B. Abid, 2017, Leukemia research reports.

Outcome of transplantation for myelofibrosis.

N. Kröger, M. Horowitz, R. Gale, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

D. Marks, J. Bird, E. Williamson, 1999, Leukemia & lymphoma.

One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.

J. Sierra, Stephanie J. Lee, O. Ringdén, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro

N. Scolding, P. Virgo, A. Wilkins, 2017, Multiple sclerosis.

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era

A. Pettitt, C. Craddock, J. Byrne, 2014, Bone Marrow Transplantation.

Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft‐versus‐host disease and relapse

P. Martiat, J. Goldman, N. Cross, 1993, British journal of haematology.

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation

A. Krishnan, W. Wood, P. Hari, 2015, Bone Marrow Transplantation.

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.

M. Norkin, W. Wood, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

syndrome and acute myeloid leukemia Allogeneic transplantation for therapy-related myelodysplastic

J. Sierra, J. Dipersio, S. Tarima, 2011 .

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.

J. Sierra, J. Dipersio, S. Tarima, 2010, Blood.

Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML

C. Craddock, R. Malladi, J. Cavenagh, 2009, Bone Marrow Transplantation.

The clinical outcome and toxicity of high‐dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British society of blood and marrow transplantation study

C. Fegan, J. Byrne, J. Snowden, 2006, British journal of haematology.

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

B. Sandmaier, M. Aljurf, R. Gale, 2016, Cancer.

Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study.

J. Delgado, N. Russell, S. Mackinnon, 2006, Blood.

Reduced intensity conditioned allograft yields favorable survival for older adults with B‐cell acute lymphoblastic leukemia

B. Sandmaier, H. Khoury, O. Ringdén, 2017, American journal of hematology.

lymphoblastic leukemia regimen enhances long-term outcomes in Philadelphia positive acute UKALLXII/ECOG2993: addition of imatinib to a standard treatment

M. Tallman, L. Foroni, G. Gerrard, 2014 .

UKALLXII / ECOG 2993 : addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia

M. Tallman, L. Foroni, G. Gerrard, 2014 .

Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study

G. Cook, B. Shaw, T. Littlewood, 2013, Bone Marrow Transplantation.

J. Szer, B. George, R. Gale, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.

C. Bloomfield, R. Larson, K. Mrózek, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

International variations in the use of haematopoietic cell transplantation for haematological malignancies: the effects of national transplant indications tables and differing access to therapies

D. Marks, J. Bird, R. Protheroe, 2017, British journal of haematology.

In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial

M. Copland, A. Moorman, M. Potter, 2022, The Lancet. Haematology.

Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia.

H. Kantarjian, W. Stock, D. DeAngelo, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Burden of hospitalization in acute lymphoblastic leukemia patients treated with Inotuzumab Ozogamicin versus standard chemotherapy treatment

H. Kantarjian, V. Welch, E. Vandendries, 2019, Cancer medicine.

Pretransplant Consolidation Is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation.

Tallman, B. Sandmaier, M. Tallman, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Inotuzumab ozogamicin in the management of acute lymphoblastic leukaemia

D. Marks, N. Morley, 2016, Expert review of anticancer therapy.

The clinical characteristics , therapy and outcome of 85 adults with acute lymphoblastic leukemia and t ( 4 ; 11 ) ( q 21 ; q 23 ) / MLL-AFF 1 prospectively treated on UKALLXII / ECOG

M. Tallman, L. Foroni, C. Harrison, 2013 .

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial

M. Tallman, S. Richards, A. Moorman, 2012, British journal of haematology.

(ALL); an MRC UKALL12/ECOG 2993 study Outcome of 609 adults after relapse of acute lymphoblastic leukaemia

S. Richards, R. Chopra, H. Lazarus, 2012 .

Alternative donor transplants for adult acute lymphoblastic leukaemia: a comparison of the three major options

F. Aversa, H. Lazarus, D. Marks, 2006, Bone Marrow Transplantation.

Treating the "older" adult with acute lymphoblastic leukemia.

D. Marks, 2010, Hematology. American Society of Hematology. Education Program.

Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia in Adults

D. Marks, 2010 .

Analysis of p53 and mdm‐2 expression in 18 patients with Sézary syndrome

D. Haines, D. Marks, D. Morgan, 1996, British journal of haematology.

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.

A. Zander, J. Szer, M. Horowitz, 2008, Blood.

PROGNOSTIC FACTORS FOR OUTCOMES IN ALLOGENEIC TRANSPLANTATION FOR ADVANCED PHASES OF CHRONIC MYELOID LEUKEMIA IN THE IMATINIB ERA: A CIBMTR ANALYSIS

J. Cortes, J. Szer, M. Horowitz, 2011, Bone Marrow Transplantation.

Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow.

J. Goldman, F. van Rhee, A. Hochhaus, 1995, Leukemia.

Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study

D. Leongamornlert, E. Papaemmanuil, A. Enshaei, 2021, Leukemia.

T cell-depleted unrelated donor bone marrow transplantation for acute myeloid leukemia.

J. Cornish, K. Vettenranta, N. Goulden, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

IKZF1 alterations are not associated with outcome in 498 adults with B-precursor ALL enrolled in the UKALL14 trial.

D. Leongamornlert, E. Papaemmanuil, A. Moorman, 2021, Blood advances.

Molecular Classification Improves Risk Assessment in Adult BCR-ABL1-negative B-ALL.

Cheng Cheng, Chunxu Qu, O. Abdel-Wahab, 2021, Blood.

Translocation 11;14 in newly diagnosed chronic myelogenous leukemia.

P. Nowell, C. Croce, J. Lasota, 1995, Cancer genetics and cytogenetics.

Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five cases

D. Swirsky, D. Marks, J. M. Goldman, 1992, British journal of haematology.

Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research

M. Horowitz, M. Bishop, Carole B. Miller, 2008, Bone Marrow Transplantation.

Influence of cytomegalovirus (CMV) sero-positivity on CMV infection, lymphocyte recovery and non-CMV infections following T-cell-depleted allogeneic stem cell transplantation: a comparison between two T-cell depletion regimens

D. Marks, D. Milligan, D. Pamphilon, 2004, Bone Marrow Transplantation.

Should we T cell deplete sibling grafts for acute myeloid leukaemia in first remission?

D. Marks, S. Chakrabarti, 2003, Bone Marrow Transplantation.

Early lymphocyte recovery is an important determinant of outcome following allogeneic transplantation with CD34+ selected graft and limited T-cell addback

D. Marks, M. Guttridge, D. Pamphilon, 2003, Bone Marrow Transplantation.

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.

A. Barrett, M. Horowitz, J. Wingard, 2009, Blood.

The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation

J. Moppett, J. Cornish, G. Taylor, 1999, Bone Marrow Transplantation.

Thrombotic Thrombocytopenic Purpura Following Stem Cell Transplantation

D. Marks, J. Bird, S. Allford, 2002, Leukemia & lymphoma.

The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation

J. Cornish, N. Goulden, D. Marks, 2001, British journal of haematology.

A Phase 3 randomized study of Remestemcel-L versus placebo added to second line therapy in patients with steroid refractory acute graft versus host disease.

E. Shpall, R. Soiffer, E. Waller, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Infections in adults undergoing unrelated donor bone marrow transplantation

J. Cornish, D. Marks, A. Oakhill, 1999, British journal of haematology.

Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.

Alan M. Miller, R. Vij, M. Aljurf, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.

M. Norkin, S. Mineishi, M. Krem, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee.

A. Paci, M. Perales, M. Mohty, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for

J. Esteve, H. Dombret, R. Foà, 2018, Bone Marrow Transplantation.

Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.

S. Crawford, P. Veys, R. Champlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation

C. Heussel, A. Glasmacher, C. Solano, 2011, British journal of haematology.

Title: Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation Overline: Transplantation Single sentence summary: Mesenchymal stromal cell apoptosis, induced in vivo by recipient

Apperley, Clare L. Bennett, F. Watt, 2018 .

Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation

Clare L. Bennett, F. Watt, T. S. Cheung, 2017, Science Translational Medicine.

Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia: No Impact of Pre-transplant Extramedullary Disease on Outcome

M. Tallman, R. Gale, T. Shea, 2015, Bone Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.

P. Hari, R. Gale, M. Cairo, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Cornish, D. Marks, J. Cornish, 1997, British journal of haematology.

Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases

Michael J. Eckrich, W. Wood, Zhezhen Jin, 2017, Haematologica.

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

B. Sandmaier, M. Horowitz, R. Gale, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

D. Weisdorf, D. Marks, Mei-Jie Zhang, 2008 .

The role of allografting in adults with acute leukaemia

D. Marks, 2008, Bone Marrow Transplantation.

Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation

D. Marks, M. Slavin, Qi-fa Liu, 2017, Expert review of anti-infective therapy.

Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia.

J. Shuster, M. Link, D. Haines, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The outcome of children requiring admission to an intensive care unit following bone marrow transplantation

J. Cornish, I. Jenkins, D. Marks, 1998, British journal of haematology.

Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents.

W. Wood, M. Sorror, H. Lazarus, 2014, Biology of Blood and Marrow Transplantation.

Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study.

H. Kantarjian, E. Jabbour, D. DeAngelo, 2017, The Lancet. Haematology.

transplantation superior to HLA-identical siblings for hematopoietic stem cell The graft-versus-leukemia effect using matched unrelated donors is not

J. Wingard, P. McCarthy, S. Spellman, 2011 .

Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation

J. Cornish, N. Goulden, D. Marks, 2005, Bone Marrow Transplantation.

The diagnostic and clinical significance of granulomas in gastrointestinal biopsies from haematopoietic transplant patients

N. Wong, D. Marks, 2020, Histopathology.

Management of important adverse events associated with inotuzumab ozogamicin: expert panel review

W. Stock, A. Merchant, Stephanie J. Lee, 2018, Bone Marrow Transplantation.

Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.

M. Norkin, M. Aljurf, J. Wingard, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.

M. Norkin, A. Barrett, M. Boeckh, 2016, Blood.

The use of stimulated granulocyte transfusions to prevent recurrence of past severe infections after allogeneic stem cell transplantation

J. Cornish, J. Kerr, E. Massey, 2003, British journal of haematology.

Haploidentical stem cell transplantation for children with acute leukaemia

J. Cornish, N. Goulden, D. Marks, 2006, British journal of haematology.

Role of Extracorporeal Membrane Oxygenation (ECMO) and Stem Cell Transplant in the Management of Acute Myeloid Leukaemia with Pulmonary Involvement

R. Dillon, D. Marks, S. Prabhu, 2022, Indian Journal of Hematology and Blood Transfusion.

Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial

M. Copland, M. McMullin, A. Moorman, 2022, The Lancet. Haematology.

EFFECTS OF SPLEEN STATUS ON EARLY OUTCOMES AFTER HEMATOPOIETIC CELL TRANSPLANTATION

M. Pasquini, K. Ballen, U. Popat, 2012, Bone Marrow Transplantation.

Primary Graft Failure after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

M. Pasquini, Xiaochun Zhu, O. Ringdén, 2015, Leukemia.

Prognostic Impact of Chromosomal Abnormalities and Copy Number Alterations Among Adults with B-Cell Precursor Acute Lymphoblastic Leukaemia Treated on UKALL14

D. Leongamornlert, E. Papaemmanuil, C. Harrison, 2019, Blood.

Genetic and Genomic Characterisation of Older Adults with Acute Lymphoblastic Leukemia Treated on the UKALL14 and UKALL60+ Clinical Trials

D. Leongamornlert, E. Papaemmanuil, J. Snowden, 2019, Blood.

Allogeneic transplantation for leukaemia using unrelated donors.

D. Marks, David I. Marks, 2001, Best practice & research. Clinical haematology.

Predictors of lost to follow-up among pediatric and adult hematopoietic cell transplant survivors: A report from the Center for International Blood and Marrow Transplant Research.

W. Wood, M. Aljurf, A. Yoshimi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.

M. Perales, A. Nagler, M. Mohty, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis.

W. Wood, R. Sparapani, R. Gale, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations.

S. Senn, C. Viscoli, J. Cooke, 2003, Clinical therapeutics.

Autotransplantation versus HLA‐matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research

J. Klein, M. Horowitz, R. Gale, 2006, British journal of haematology.

Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction

D. Marks, H. Palmer, J. Leeming, 2000, British journal of haematology.

Gram-negative bacteraemia (GNB) after 428 unrelated donor bone marrow transplants (UD-BMT): risk factors, prophylaxis, therapy and outcome

D. Marks, A. Oakhill, P. Derrington, 2004, Bone Marrow Transplantation.

Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant

S. Sorensen, C. Solano, D. Vanness, 2017, Mycoses.

The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR® analysis

Allen R. Chen, M. Boeckh, M. Aljurf, 2015, Bone Marrow Transplantation.

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

J. Wagner, M. Horowitz, R. Gale, 2004, The New England journal of medicine.

Association between drug tolerability and medical resource use in prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplant

H. Schlamm, D. Marks, M. Tarallo, 2013, Journal of medical economics.

Virus detection in the cerebrospinal fluid of hematopoietic stem cell transplant recipients is associated with poor patient outcomes: a CIBMTR contemporary longitudinal study

P. Hari, J. Wingard, R. Gale, 2019, Bone Marrow Transplantation.

M. Pasquini, K. Ballen, H. Lazarus, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants

S Mackinnon, N H Russell, J A Madrigal, 2017, Bone Marrow Transplantation.

Title : Recipient / Donor HLA and CMV matching in recipients of T cell depleted 1 unrelated donor haematopoietic cell transplants 2 3 4 Short title : Donor factors in transplant outcome 5 6

S. Mackinnon, J. Madrigal, A. Clark, 2016 .

Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.

M. Tallman, R. Gale, M. Flowers, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.

Mei-Jie Zhang, David D. Smith, David D Smith, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

J. Klein, M. Tallman, A. Keating, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

M. Krem, C. Hourigan, M. Aljurf, 2021, Blood advances.

Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population‐based survey *

G. Jackson, D. Marks, M. Velangi, 2005, British journal of haematology.

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.

J. Wagner, M. Horowitz, R. Soiffer, 2010, The Lancet. Oncology.

Patient‐reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia

H. Kantarjian, J. Cappelleri, E. Jabbour, 2018, Cancer.

Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.

M. Sorror, J. Wingard, U. Popat, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.

Alan M. Miller, R. Vij, F. Baron, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Vose, P. Hari, R. Gale, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning.

J. Vose, P. Hari, R. Gale, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.

John P Klein, Daniel J Weisdorf, Ciril Rozman, 2002, Blood.

Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.

J. Klein, W. Wood, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of coagulopathy before and during induction chemotherapy for acute lymphoblastic leukaemia, including assessment of global clotting tests

C. Bradbury, J. Moppett, A. Mumford, 2017, Blood Cancer Journal.

Advising patients seeking stem cell interventions for multiple sclerosis

N. Scolding, A. Wilkins, D. Marks, 2018, Practical Neurology.

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research

R. Vij, B. Sandmaier, M. Aljurf, 2019, Haematologica.

Diverging effects of HLA–DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles

S Mackinnon, N H Russell, J A Madrigal, 2010, Leukemia.

Management of adults with T-cell lymphoblastic leukemia.

D. Marks, C. Rowntree, 2017, Blood.

Guidelines on the management and admission to intensive care of critically ill adult patients with haematological malignancy in the UK

M. Wise, D. Marks, S. Baudouin, 2015, British journal of haematology.

The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial

M. Tallman, L. Foroni, G. Dewald, 2013, Haematologica.

Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials

D. Leongamornlert, E. Papaemmanuil, C. Harrison, 2021, Haematologica.

First Analysis of the UKALL14 Randomized Trial to Determine Whether the Addition of Nelarabine to Standard Chemotherapy Improves Event Free Survival in Adults with T-Cell Acute Lymphoblastic Leukaemia (CRUK/09/006)

A. Moorman, A. Fielding, L. Clifton-Hadley, 2021, Blood.

A Prognostic Model Predicting Autologous Transplantation Outcomes in Children, Adolescents and Young Adults with Hodgkin Lymphoma

J. Vose, Sonali M. Smith, W. Wood, 2015, Bone Marrow Transplantation.

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: comparative toxicity and outcomes.

J. Klein, J. Sierra, M. Horowitz, 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Safety and Feasibility of Autologous Bone Marrow Cellular Therapy in Relapsing‐Progressive Multiple Sclerosis

D. Brooks, S. R. Butler, A. Whone, 2010, Clinical pharmacology and therapeutics.

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.

J. Dipersio, M. Tallman, R. Gale, 2010, Blood.

HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.

R. Schlenk, H. Döhner, A. Ganser, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.

Alan M. Miller, P. D. Dal Cin, J. Sierra, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

N. Goulden, D. Marks, J. Cornish, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.

A. Gratwohl, J. Szer, M. Horowitz, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The clinical features and outcome of 2009 H1N1 influenza infection in allo-SCT patients: a British Society of Blood and Marrow Transplantation study

S. Nagra, G. Cook, M. Gilleece, 2012, Bone Marrow Transplantation.

The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation

N. Goulden, D. Marks, A. Oakhill, 2002, British journal of haematology.

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia.

G. Mufti, N. Russell, R. Ireland, 2011, Blood.

Recipient‐derived HPA‐1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation

N. Russell, E. Massey, D. Allen, 2010, Transfusion.

Older patients with myeloma derive similar benefit from autologous transplantation.

A. Krishnan, S. Lonial, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors

N. Russell, S. Mackinnon, J. Madrigal, 2016, Haematologica.

Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols

C. Craddock, C. Crawley, N. Russell, 2016, British journal of haematology.

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

M. Tallman, O. Ringdén, R. Martino, 2004, Bone Marrow Transplantation.

In pursuit of the allo-immune response in multiple myeloma: where do we go from here?

G. Cook, D. Marks, J. Bird, 2009, Bone Marrow Transplantation.

HLA‐identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome

A. Barrett, S. Mackinnon, J. Goldman, 1992, British journal of haematology.

Sexual dysfunction prior to high-dose chemotherapy and bone marrow transplantation.

P. Crilley, D. Marks, A. Nezu, 1996, Bone marrow transplantation.

Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT.

M. Aljurf, R. Gale, J. Pidala, 2020, Journal of Clinical Oncology.

GVHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes

M. Aljurf, I. Lewis, R. Gale, 2016, Bone Marrow Transplantation.

Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor?

J. Wagner, M. Perales, H. Lazarus, 2019, Haematologica.

A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.

Alan M. Miller, J. Armitage, J. Vose, 2003, Blood.

M. Perales, F. Appelbaum, J. Pidala, 2014, Haematologica.

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

D. Porter, M. Horowitz, R. Soiffer, 2011, Blood.

Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission

C. Craddock, N. Russell, R. Clark, 2009, Haematologica.

Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogenic bone marrow transplantation.

P. Crilley, D. Marks, E. Bernstein, 1995, Bone marrow transplantation.

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

G. Mufti, N. Russell, J. Cavenagh, 2008, Bone Marrow Transplantation.

Outcome of Second Allogeneic Transplants Using Reduced Intensity Conditioning Following Relapse after an Initial Allogeneic Transplant.

G. Mufti, C. Craddock, N. Russell, 2006 .

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and minimal residual disease

M. Norkin, R. Vij, M. Aljurf, 2013, Leukemia.

The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasma

B. Kahan, J. Moppett, S. Stanworth, 2012, Transfusion medicine.

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

Ruta Bajorunaite, Arturo Molina, John Gibson, 2003, Blood.

Donor characteristics affecting graft failure, graft-versus-host disease, and survival after unrelated donor transplantation with reduced-intensity conditioning for hematologic malignancies.

A. Gratwohl, J. Passweg, H. Lazarus, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure.

Alan M. Miller, J. Vose, Sonali M. Smith, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

Zhiwei, Saber, M. Norkin, 2014 .

S. Mackinnon, N. Cross, H. Waldmann, 1993, Bone marrow transplantation.

C. Craddock, N. Russell, J. Snowden, 2016, British journal of haematology.

Patient/Donor CMV Matching Is a Critical Determinant of Survival in Unrelated Donor Haematopoietic Stem Cell Transplantation

N. Russell, S. Mackinnon, J. Madrigal, 2014 .

BEAM-Campath allogeneic stem cell transplant for patients with relapsed/refractory lymphoma - High incidence of long term mixed donor-recipient chimerism and the response to donor lymphocyte infusions.

D. Marks, S. Robinson, James E. Griffin, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Results of a phase I/II British Society of Bone Marrow Transplantation study on PCR-based pre-emptive therapy with valganciclovir or ganciclovir for active CMV infection following alemtuzumab-based reduced intensity allogeneic stem cell transplantation.

G. Mufti, M. Zuckerman, D. Marks, 2009, Leukemia research.

Salvage second hematopoietic cell transplantation in myeloma.

J. Vose, A. Krishnan, S. Lonial, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study.

James Robinson, N. Russell, S. Mackinnon, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.

Rajesh Chopra, M. Tallman, S. Richards, 2007, Blood.

High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis.

J. Shuster, M. Link, D. Haines, 1996, Blood.

Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated

S. Nikiforow, H. Nakasone, J. Pidala, 2018, Haematologica.

(2019). Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study. Biology of Blood and Marrow Transplantation , 25 (3), 443-450.

N. Russell, S. Mackinnon, J. Madrigal, 2019 .

Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.

M. Norkin, M. Boeckh, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.

J. Cortes, M. Aljurf, M. Tallman, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for relapsed and refractory mantle cell lymphoma (MCL): a study of the British Society for Blood and Marrow Transplantation.

C. Craddock, N. Russell, G. Cook, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation.

J. Cavenagh, R. Chopra, A. Davies, 2002, Blood.

The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma

N. Russell, J. Cavenagh, K. Peggs, 2003, British journal of haematology.

Engraftment of T‐cell‐depleted allogeneic haematopoietic stem cells using a reduced intensity conditioning regimen

C. Craddock, J. Goldman, S. Kreiter, 2000, British journal of haematology.

Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.

J. Cortes, M. Aljurf, J. Szer, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

J. Cortes, M. Aljurf, J. Szer, 2013, Blood.

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report

J. Mehta, M. Perales, N. Saba, 2019, Clinical Cancer Research.

Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.

E. Guinan, M. Aljurf, M. Pasquini, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.

J. Vose, S. Montoto, Sonali M. Smith, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR‐ligand mismatch after dose‐reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma

N. Kröger, S. Iacobelli, A. Zander, 2005, British journal of haematology.

Patients' Experiences of Appearance Changes Following Allogeneic Bone Marrow Transplantation

C. Russell, D. Harcourt, D. Marks, 2011, Cancer nursing.

Long‐term outcomes among 2‐year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b‐cell lymphoma

W. Wood, Z. DeFilipp, B. Shaw, 2018, Cancer.

with TBI following cyclophosphamide in combination with busulfan compared Better leukemia-free and overall survival in AML in first remission

J. Cortes, M. Aljurf, J. Szer, 2013 .

The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy.

C. Crawley, N. Russell, R. Clark, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide–total body irradiation versus busulphan–cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission

J. Klein, R. Gale, M. Trigg, 2002, British journal of haematology.

Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia.

J. Liesveld, Z. DeFilipp, B. Shaw, 2020, Blood advances.

Inferior Outcomes with Cyclosporine and Mycophenolate mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.

M. Aljurf, R. Gale, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Therapy of primary diffuse large cell lymphoma of the penis with preservation of function.

G. Varigos, D. Marks, G. Morstyn, 1988, The Journal of urology.

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission.

J. Szer, B. George, M. Tallman, 2010, Blood.

Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research

J. Szer, M. Tallman, K. Ballen, 2013, Haematologica.

Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative

C. Craddock, E. Tholouli, C. Crawley, 2020, Bone Marrow Transplantation.

Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome–positive relapsed/refractory acute lymphoblastic leukemia

M. Liedtke, H. Kantarjian, G. Martinelli, 2020, Cancer.

Impact of Early Cytomegalovirus Reactivation in Cord Blood Stem Cell Recipients in the Current Era

Riches, M. Boeckh, H. Lazarus, 2016 .

Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the clinical trials committee of the British Society of Blood & Marrow Transplantation (BSBMT)

N. Russell, R. Clark, F. Dazzi, 2005, Bone Marrow Transplantation.

Better HLA Matching as Revealed Only by Next Generation Sequencing Technology Results in Superior Overall Survival Post-Allogeneic Haematopoietic Cell Transplantation with Unrelated Donors

N. Russell, S. Mackinnon, J. Madrigal, 2018 .

Allogeneic hematopoietic cell transplant for prolymphocytic leukemia.

J. Cortes, J. Szer, M. Horowitz, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia.

M. Norkin, B. Sandmaier, B. George, 2019, Blood advances.

Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma.

P. Hari, R. Gale, Y. Nieto, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study

J. Gribben, S. Mackinnon, D. Linch, 2008, Hematology.

Risk Factors and Impact of non-Aspergillus mold infections (NAMI) following Allogeneic HCT: A CIBMTR Infection & Immune Reconstitution analysis

J. Wingard, C. Bennett, S. Trifilio, 2015, Bone Marrow Transplantation.

Maintenance versus Induction Therapy Choice on Outcomes after Autologous Transplantation for Multiple Myeloma.

A. Krishnan, R. Vij, P. Hari, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

POST-INDUCTION MRD PREDICTS HIGH RELAPSE RISK FOLLOWING REDUCED INTENSITY CONDITIONED ALLOGENEIC STEM CELL TRANSPLANTATION: A PROSPECTIVE STUDY OF ADULT ALL (UKALL14, ISRCTN 66541317)

A. Fielding, L. Clifton-Hadley, E. Lawrie, 2017 .

J. Sierra, M. Tallman, R. Gale, 2008, Blood.

Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.

A. Krishnan, S. Lonial, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis

J. Wingard, C. Bennett, S. Trifilio, 2016, Bone Marrow Transplantation.

Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival

E. Tholouli, J. Snowden, A. Vora, 2019, British journal of haematology.

Mesenchymal stromal cells for the treatment of steroid-resistant acute graft versus host disease: factors influencing clinical responses.

E. Tholouli, J. Snowden, A. Vora, 2017 .

Preparations for unrelated donor transplantation

D. Marks, 2006, Leukemia & lymphoma.

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.

R. Vij, M. Aljurf, R. Gale, 2022, JAMA oncology.

Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.

M. Aljurf, L. Diller, R. Gale, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.

J. Moul, J. Szer, E. Copelan, 1996, Bone marrow transplantation.

Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden.

P. Hari, M. Krem, R. Kyle, 2021, Transplantation and cellular therapy.

Introduction to haematopoietic stem cell transplantation

D. Marks, E. Liakopoulou, 2008 .

Autologous mesenchymal bone marrow stem cells: Practical considerations

N. Scolding, D. Marks, C. Rice, 2008, Journal of the Neurological Sciences.

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

B. Sandmaier, M. Perales, A. Nagler, 2020, Blood advances.

Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.

J. Vose, J. Winter, P. Hari, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR).

Alan M. Miller, J. Armitage, J. Vose, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study

G. Cook, D. Marks, S. Feyler, 2007, Bone Marrow Transplantation.

lymphoblastic leukemia in first complete remission Unrelated donor transplants in adults with Philadelphia-negative acute

J. Sierra, R. Gale, M. Bishop, 2011 .

Are reduced-intensity transplants safe in older patients with hematologic malignancies?

D. Marks, R. Protheroe, 2012, Expert review of hematology.

Obesity does not preclude safe and effective myeloablative hematopoietic cell transplantation (HCT) for acute myelogenous leukemia (AML) in adults.

M. Pasquini, K. Ballen, J. Liesveld, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.

J. Sierra, A. Zander, M. Horowitz, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States.

M. Krem, Stephanie J. Lee, K. Syrjala, 2021, Transplantation and cellular therapy.

Sibling versus Unrelated Donor Allogeneic Hematopoietic Cell Transplantation for CML: Refined HLA-matching shows more GVHD but not less relapse Blood Marrow

J. Szer, M. Horowitz, Stephanie J. Lee, 2010 .

To the editor : Hemoglobin normalization after splenectomy in a paroxysmal nocturnal hemoglobinuria patient treated by eculizumab

D. Marks, 2022 .

Comparison between Anti-Thymocyte Globulin and Alemtuzumab and the Possible Impact of KIR-Ligand Mismatch in Melphalan/Fludarabine Dose-Reduced Conditioning Followed by HLA-Matched and Mismatched Unrelated Stem Cell Transplantation in Patients with Multiple Myeloma.

S. Iacobelli, A. Nagler, K. Peggs, 2004 .

K. Ballen, H. Lazarus, L. Isola, 2008 .

Does Imatinib Change the Outcome in Philapdelphia Chromosome Positive Acute Lymphoblastic Leukaemia in Adults? Data from the UKALLXII/ECOG2993 Study.

M. Tallman, S. Richards, H. Lazarus, 2007 .

Post-allograft relapse of acute lymphoblastic leukemia: rational use of the new targeted therapies

D. Marks, C. Furness, 2018, Current medical research and opinion.

Necrosis of myeloma-infiltrated ileum following cytotoxic chemotherapy.

D. Marks, F. Firkin, 1987, Australian and New Zealand journal of medicine.

The effect of smoking on allogeneic transplant outcomes.

K. Ballen, O. Ringdén, P. McCarthy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Repeat infusion of autologous bone marrow cells in progressive multiple sclerosis - A phase I extension study (SIAMMS II).

P. Walsh, N. Kane, N. Scolding, 2022, Multiple sclerosis and related disorders.

First Analysis of the UKALL14 Phase 3 Randomised Trial to Determine If the Addition of Rituximab to Standard Induction Chemotherapy Improves EFS in Adults with Precursor B-ALL (CRUK/09/006)

A. Moorman, A. Fielding, L. Clifton-Hadley, 2019, Blood.

Extensive safety profile of inotuzumab ozogamicin (InO) in relapsed/refractory acute lymphoblastic leukemia (ALL) patients enrolled in the phase 3 INO-VATE trial.

M. Liedtke, H. Kantarjian, G. Martinelli, 2018 .

Impact of number of cycles on outcomes of patients with relapsed or refractory acute lymphoblastic leukaemia treated with inotuzumab ozogamicin

H. Kantarjian, E. Jabbour, W. Stock, 2020, British journal of haematology.

Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial

P. Morgan, Y. Ben-Shlomo, N. Evangelou, 2015, Trials.

Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial

M. Tallman, S. Richards, A. Moorman, 2010 .

Impact of salvage treatment phase on inotuzumab ozogamicin treatment for relapsed/refractory acute lymphoblastic leukemia: an update from the INO-VATE final study database

H. Kantarjian, E. Jabbour, W. Stock, 2020, Leukemia & lymphoma.

Comparison of Outcomes for Non-Myeloablative (NMA) and Myeloablative (MA) Conditioning for Adults with Acute Lymphoblastic Leukaemia (ALL) in First and Second Complete Remission (CR): a Center for International Blood and Marrow Transplant Research (CIBMTR) Analyisis.

J. Dipersio, M. Tallman, Tao Wang, 2009 .

Standard Consolidation/Maintenance Chemotherapy Is Consistently Superior to a Single Autologous Transplant for Adult Patients with Acute Lymphoblastic Leukemia: Results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

M. Tallman, S. Richards, G. Dewald, 2008 .

The impact of donor type on outcomes and cost of allogeneic hematopoietic cell transplant for pediatric leukemia: a merged CIBMTR and PHIS analysis: Pediatric acute leukemia transplant risks and utilization.

W. Wood, D. Rizzieri, H. Lazarus, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II)

P. Walsh, N. Kane, N. Scolding, 2015, BMJ Open.

Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report

P. Hari, R. Gale, Y. Nieto, 2017, Cancer.

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation

C. Heussel, A. Glasmacher, C. Solano, 2011, British journal of haematology.

Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII

P. Gimotty, M. Tallman, J. Gelfand, 2016, American journal of hematology.

The outcome of high-dose chemotherapy and auto-SCT in patients with multiple myeloma: a UK/Ireland and European benchmarking comparative analysis

G. Morgan, N. Russell, G. Cook, 2011, Bone Marrow Transplantation.

Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia (B-ALL) Patients (pts) From the International UKALLXII/E2993 Trial: No Difference In Results Between B Cell Immunophenotypic Subgroups

M. Tallman, S. Richards, G. Dewald, 2010 .

At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial

C. Mullighan, C. Willman, M. Tallman, 2020, British journal of haematology.

A Stem Cell Donor for Every Adult Requiring an Allograft for Acute Lymphoblastic Leukemia?

D. Marks, M. B. Abid, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T-Cell Depleted Unrelated Donor Stem Cell Transplants Appear to Be of Value for Adult Philadelphia Chromosome Negative ALL Patients and Should Be Evaluated Prospectively in New Large Group Studies

C. Craddock, N. Russell, R. Clark, 2008 .

Younger Matched Unrelated Donors Confer Decreased Relapse Compared to Older Sibling Donors in Older B-cell ALL Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

C. Hourigan, C. Bredeson, D. Marks, 2023, Transplantation and cellular therapy.

‘Rainy day’ stem cell storage for adult patients with acute myeloid leukaemia in first complete remission

D. Marks, 2008, Internal medicine journal (Print).

Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.

C. Craddock, J. Snowden, K. Peggs, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Conditioning regimens for acute lymphoblastic leukaemia allografts

D. Marks, 2007, Bone Marrow Transplantation.

Stenotrophomonas maltophilia bacteraemia in 40 haematology patients: risk factors, therapy and outcome

R. Heyderman, J. Moppett, D. Marks, 2010, Bone Marrow Transplantation.

Feasibility Of Pegylated-Asparaginase (PEG-ASP) During Induction In Adults With Acute Lymphoblastic Leukaemia (ALL): Results From The UK Phase 3 Multicentre Trial UKALL 14

A. Fielding, Paul D. Smith, T. Menne, 2013 .

Tallman, P. Gimotty, J. Gelfand, 2017, American journal of hematology.

L. Staudt, D. Weisenburger, J. Vose, 2007 .

T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL

A. Ferrando, M. Tallman, S. Richards, 2009 .

SECOND MALIGNANCIES AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN CHILDREN

W. Wood, M. Sorror, J. Wingard, 2012, Bone Marrow Transplantation.